Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
146 hedge funds and large institutions have $539M invested in Surmodics in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 53 increasing their positions, 45 reducing their positions, and 10 closing their positions.
60% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 10
18% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 45
4% more funds holding
Funds holding: 140 → 146 (+6)
3% more capital invested
Capital invested by funds: $521M → $539M (+$17.2M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.89% less ownership
Funds ownership: 90.19% → 87.29% (-2.9%)
62% less call options, than puts
Call options by funds: $407K | Put options by funds: $1.06M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$6.27M |
| 2 |
Goldman Sachs
New York
|
+$4.23M |
| 3 |
Janus Henderson Group
London,
|
+$1.86M |
| 4 |
BlackRock
New York
|
+$1.79M |
| 5 |
MSL
Mackay Shields LLC
New York
|
+$1.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$3.85M |
| 2 |
Renaissance Technologies
New York
|
-$3.53M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.39M |
| 4 |
D.E. Shaw & Co
New York
|
-$3.2M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$2.88M |
SRDX Hedge Fund Activity: Q3 2019 in Review
146 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q3 2019, worth a combined $539M — up 3.3% from $521M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new SRDX positions and 10 closed out — a net gain of 6 holders — while 53 added to existing stakes and 45 trimmed.
The largest buyer was Trigran Investments, adding an estimated $6.27M. The largest seller was Caption Management, exiting entirely with an estimated $3.85M sold.
- 146 institutional investors held Surmodics (SRDX) as of Q3 2019, up from 140 in Q2 2019.
- Funds reported $539M of Surmodics stock for Q3 2019, up 3.3% quarter-over-quarter.
- 16 funds opened new Surmodics positions in Q3 2019 and 10 closed out, a net change of +6 holders.
- The largest Surmodics buyer in Q3 2019 was Trigran Investments, an estimated $6.27M added.
- The largest Surmodics seller in Q3 2019 was Caption Management, an estimated $3.85M sold.
Based on aggregated 13F filings for Q3 2019.